Retail Clinics

  • NCPP: Preventative health services can save lives, money

    MINNEAPOLIS Preventative health services, such as daily aspirin use, tobacco-cessation screening and alcohol-abuse screening potentially can save 2 million lives and nearly $4 billion annually, according to a new paper produced by the National Commission on Prevention Priorities.

     

  • LifeNexus introduces personal health card

    BROOMFIELD, Colo. LifeNexus recently introduced its personal health card, a dual-purpose payment/loyalty card that comes equipped with an embedded microprocessor, the iChip, designed for an individually controlled health platform.

     

    The personal health card can be used to maintain personal health records by securely transferring accurate information at the time and point of need. This will allow professionals access to a patient’s personal health record through card-based consumer authorization, which is both encrypted and password-protected.

  • Former MinuteClinic exec shifts to Santa Rosa Community Health Centers

    SANTA ROSA, Calif. Former MinuteClinic regional medical director Francisco Trilla has joined Santa Rosa Community Health Centers, according to local news reports.

    Trilla will serve as the new chief medical officer of Santa Rosa Community Health Centers, overseeing clinical programs at all of its eight facilities with "an emphasis on access and quality," according to reports.

  • Study: Patients increasingly turn to ER for acute ailments

    NEW YORK Millions of patients with such acute ailments as fevers and coughs turn to the emergency room for treatment, according to researchers. The findings serve as yet one more indicator for the need of convenient and affordable health services available at retail-based clinics.

  • Teva markets AcuDial generic

    NORTH WALES, Pa. Teva Pharmaceuticals has launched a generic treatment for epileptic seizures.

     

    The world’s largest generic drug maker announced Wednesday the launch of diazepam rectal gel, a generic version of Valeant Pharmaceuticals’ Diastat AcuDial. The drug is administered via rectal syringe and is available in 2.5-mg, 10-mg and 20-mg strengths.

     

     

  • Target looks to expand clinic business

    MINNEAPOLIS Target is looking to open eight new Target Clinic locations in Chicago and Palm Beach, Fla., in September.

    Target currently has 28 clinics in Minnesota and Maryland, according to the website. The healthcare services in Minnesota and Maryland are provided by Target Clinic Medical Associates, an unaffiliated corporation not owned or operated by Target Corp. Fees for most services range from $59 to $69.

  • 'Multifaceted strategies' can improve medication adherence among patients

    SAN DIEGO Improving medication adherence will require bringing multiple methods together in order to be successful, Pharmacy Quality Alliance senior director for research and performance measurement David Nau said Tuesday in an education session at the National Association of Chain Drug Stores’ Pharmacy and Technology Conference in San Diego.

     

    “You need to have a multifaceted strategy around adherence if you want to have an impact on adherence,” Nau said.

     

     

  • FDA to discuss concerns over medicines with DXM

    SILVER SPRING, Md. The Food and Drug Administration last week issued an information packet in preparation for a Sept. 14 advisory committee meeting that will address the potential abuse of dextromethorphan products and whether restrictions should be placed on the sale of those over-the-counter cough medicines.

     

    Members of both the FDA Drug Safety and Risk Management Advisory Committee and the FDA Nonprescription Drugs Advisory Committee will be in attendance at the public meeting.

     

     

  • Allergan's elevated intraocular pressure treatment gets nod from FDA

    IRVINE, Calif. Allergan's optimized reformulation of Lumigan has received approval from the Food and Drug Administration, the drug maker said Wednesday.

    Lumigan 0.01% (bimatoprost ophthalmic solution) is a first-line therapy indicated for the reduction of elevated intraocular pressure with open-angle glaucoma or ocular hypertension, Allergan said. Lumigan 0.01% will be available in fourth quarter 2010 as the newest addition to Allergan’s comprehensive glaucoma portfolio.

     

  • Salmonella not a threat to flu vaccine production

    NEW YORK Despite concerns that this year's flu vaccine production will be affected by the recent salmonella outbreak, a Food and Drug Administration official and a drug maker advised that is not the case, according to published reports.

    Although chicken eggs, which were said to be the source of this summer's salmonella outbreak, are used to make the flu vaccine, an FDA spokeswoman said that chicken eggs used in creating the flu vaccine are fertilized, unlike those used for consumption.

X
This ad will auto-close in 10 seconds